
Sign up to save your podcasts
Or


Medical Disclaimer: We are not doctors. The content in this video is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Any compounds discussed may be intended for research purposes only. Use at your own risk.
Welcome back, warriors! In this week's Peptide Q&A, JD Denham and William T. Haas sit down with returning guest Paul Bakhtiar president of telehealth for one of the largest peptide manufacturers in the country and keynote speaker at major peptide conferences for a deep dive into the entire growth hormone peptide category, IGF-1 LR3 protocols, how to stack without overlapping pathways, male fertility, and much more.
Chapters:
00:00 – Intro to Peptides & Telehealth
06:01 – Growth Hormone Overview
11:50 – Timing & Dosing Peptides
18:04 – AOD 9604 & Fat Loss
25:55 – Optimizing GH & Bloodwork
30:23 – GH Peptides Breakdown (Tesa, CJC, Sermorelin)
35:40 – Peptide Blends & Side Effects
44:29 – HGH Risks, Legality & Hormones
51:21 – Slu-PP-332 & Fat Loss
54:11 – Fasting, Cancer & Healing (BPC-157)
1:01:41 – NAD+, Protocols & Final Takeaways
We cover:
• Mixing Multiple Peptides in One Syringe: Why it's safe, how to do it right, and why you don't need to be a pin cushion
• The Full GH Peptide Hierarchy Explained: HGH vs. secretagogues vs. IGF-1 LR3 — what replaces, stimulates, and bypasses your natural growth hormone and when to use each
• IGF-1 LR3 Timing, Dosing & Cycle Length: Pre- vs. post-workout debate, why 20–40 mcg is the sweet spot, and why four to six weeks on with equal time off is the smart approach
• Tesamorelin vs. Sermorelin vs. CJC-1295: Strength rankings, dosing protocols, pituitary vs. blood plasma signaling, and why Tessa is Paul's top pick
• Ipamorelin Ratios for Women: Why equal blends can cause water retention and the case for keeping Ipa lower relative to Tessa or CJC
• IGF-1 Sweet Spot on Blood Work: Why 250–350 is the optimal range for fat loss, lean muscle, sleep quality, and cognitive function
• AOD-9604 & SLU-PP-332 Fat Loss Protocols: Proper AOD dosing, fasted cardio timing, and what the latest sloop studies show at higher milligram doses
• SS-31 Then MOTS-C for Mitochondrial Health: How to sequence them, the loading and maintenance phase for metabolic damage, and managing histamine reactions
• NAD+ Dosing Done Right — and What Happens When You Overdo It: Why 200mg per week is the sweet spot and what happens when you accidentally take 500mg
• Optimal Blood Work Markers for Testosterone: Total, free, DHEA, and SHBG targets for men and women — and why DHEA is a $25 fix most people overlook
• Male Fertility Protocol: HCG dosing, HMG every other day, N-clomiphene citrate, and why Paul avoids standard clomid
• BPC-157, Angiogenesis & Cancer Research: What the latest rat model studies show about wound healing vs. chaotic angiogenesis and why the risk conversation is shifting
📌 Subscribe for weekly, no-fluff protocols, dosing guidance, and real-world results.
You're a warrior. Act like one.
Follow Paul Bakhtiar:
Instagram: https://www.instagram.com/paulbakhtiar/
His Links: https://thepeptidepro.co/linktree
Follow us on social media:
JD's Instagram: https://www.instagram.com/jd_denham_fit
Will's Instagram: https://www.instagram.com/williamthaas/
Join The Community: https://www.skool.com/peptideresearchinstitute/about
By JD Denham and Will Haas4.7
6464 ratings
Medical Disclaimer: We are not doctors. The content in this video is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Any compounds discussed may be intended for research purposes only. Use at your own risk.
Welcome back, warriors! In this week's Peptide Q&A, JD Denham and William T. Haas sit down with returning guest Paul Bakhtiar president of telehealth for one of the largest peptide manufacturers in the country and keynote speaker at major peptide conferences for a deep dive into the entire growth hormone peptide category, IGF-1 LR3 protocols, how to stack without overlapping pathways, male fertility, and much more.
Chapters:
00:00 – Intro to Peptides & Telehealth
06:01 – Growth Hormone Overview
11:50 – Timing & Dosing Peptides
18:04 – AOD 9604 & Fat Loss
25:55 – Optimizing GH & Bloodwork
30:23 – GH Peptides Breakdown (Tesa, CJC, Sermorelin)
35:40 – Peptide Blends & Side Effects
44:29 – HGH Risks, Legality & Hormones
51:21 – Slu-PP-332 & Fat Loss
54:11 – Fasting, Cancer & Healing (BPC-157)
1:01:41 – NAD+, Protocols & Final Takeaways
We cover:
• Mixing Multiple Peptides in One Syringe: Why it's safe, how to do it right, and why you don't need to be a pin cushion
• The Full GH Peptide Hierarchy Explained: HGH vs. secretagogues vs. IGF-1 LR3 — what replaces, stimulates, and bypasses your natural growth hormone and when to use each
• IGF-1 LR3 Timing, Dosing & Cycle Length: Pre- vs. post-workout debate, why 20–40 mcg is the sweet spot, and why four to six weeks on with equal time off is the smart approach
• Tesamorelin vs. Sermorelin vs. CJC-1295: Strength rankings, dosing protocols, pituitary vs. blood plasma signaling, and why Tessa is Paul's top pick
• Ipamorelin Ratios for Women: Why equal blends can cause water retention and the case for keeping Ipa lower relative to Tessa or CJC
• IGF-1 Sweet Spot on Blood Work: Why 250–350 is the optimal range for fat loss, lean muscle, sleep quality, and cognitive function
• AOD-9604 & SLU-PP-332 Fat Loss Protocols: Proper AOD dosing, fasted cardio timing, and what the latest sloop studies show at higher milligram doses
• SS-31 Then MOTS-C for Mitochondrial Health: How to sequence them, the loading and maintenance phase for metabolic damage, and managing histamine reactions
• NAD+ Dosing Done Right — and What Happens When You Overdo It: Why 200mg per week is the sweet spot and what happens when you accidentally take 500mg
• Optimal Blood Work Markers for Testosterone: Total, free, DHEA, and SHBG targets for men and women — and why DHEA is a $25 fix most people overlook
• Male Fertility Protocol: HCG dosing, HMG every other day, N-clomiphene citrate, and why Paul avoids standard clomid
• BPC-157, Angiogenesis & Cancer Research: What the latest rat model studies show about wound healing vs. chaotic angiogenesis and why the risk conversation is shifting
📌 Subscribe for weekly, no-fluff protocols, dosing guidance, and real-world results.
You're a warrior. Act like one.
Follow Paul Bakhtiar:
Instagram: https://www.instagram.com/paulbakhtiar/
His Links: https://thepeptidepro.co/linktree
Follow us on social media:
JD's Instagram: https://www.instagram.com/jd_denham_fit
Will's Instagram: https://www.instagram.com/williamthaas/
Join The Community: https://www.skool.com/peptideresearchinstitute/about

5,007 Listeners

12,154 Listeners

342 Listeners

12 Listeners

121 Listeners

521 Listeners

300 Listeners

1,685 Listeners

1,246 Listeners

102 Listeners

41 Listeners

34 Listeners

3,131 Listeners

20 Listeners

15 Listeners